Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Poteligeo for the Treatment of Mycosis Fungoides and Sezary Syndrome

Poteligeo® (mogamulizumab-kpkc) is indicated for the treatment of mycosis fungoides and Sézary syndrome. Image courtesy of Kyowa Hakko Kirin.

  • Poteligeo®
  • Poteligeo®
  • Poteligeo®

Go Top